Division of Liver Diseases, Mount Sinai School of Medicine, 1425 Madison Ave, Room 11-76, New York, NY 10029, USA.
Best Pract Res Clin Gastroenterol. 2011 Apr;25(2):195-206. doi: 10.1016/j.bpg.2011.02.005.
Multiple etiologies of liver disease lead to liver fibrosis through integrated signaling networks that regulate the deposition of extracellular matrix. This cascade of responses drives the activation of hepatic stellate cells (HSCs) into a myofibroblast-like phenotype that is contractile, proliferative and fibrogenic. Collagen and other extracellular matrix (ECM) components are deposited as the liver generates a wound-healing response to encapsulate injury. Sustained fibrogenesis leads to cirrhosis, characterized by a distortion of the liver parenchyma and vascular architecture. Uncovering the intricate mechanisms that underlie liver fibrogenesis forms the basis for efforts to develop targeted therapies to reverse the fibrotic response and improve the outcomes of patients with chronic liver disease.
多种肝脏疾病的病因通过整合信号网络导致肝纤维化,这些信号网络调节细胞外基质的沉积。这一连串的反应促使肝星状细胞(HSCs)激活为具有收缩性、增殖性和纤维生成性的肌成纤维细胞样表型。胶原和其他细胞外基质(ECM)成分的沉积是肝脏对损伤进行包裹以产生伤口愈合反应的结果。持续的纤维化导致肝硬化,其特征为肝实质和血管结构的扭曲。揭示肝纤维化的复杂机制是努力开发靶向治疗以逆转纤维化反应并改善慢性肝病患者预后的基础。